Added to YB: 2022-11-30
Pitch date: 2022-11-30
IVRO [bullish]
InVitro International, Inc.
+55.32%
current return
Author Info
Company Info
InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally.
Market Cap
$2.1M
Pitch Price
$0.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.34
P/E
22.75
EV/Sales
1.39
Sector
Health Care Equipment and Supplies
Category
growth
IVRO You Can Taste the Potential
IVRO: Pioneering non-animal testing co since '85, now at inflection point. Corrositex & Ocular Irritection gaining global reg adoption (OECD). Profitable, debt-free, $1.25M mkt cap w/ $1.17M cash. New mgmt ('17-'19) pushing growth: PR, IR, M&A (LOI to buy profitable lab). Huge runway w/ Animal test bans (China, US states), but stock hit after run-up to $0.28. Tight float, 35% insider owned.
Read full article (6 min)